Our Planet, Our Health Convention

Health Risks Amplified

The U.S. Environmental Protection Agency's reversal of the endangerment finding on February 12, 2026, marks a significant setback in addressing climate change's health effects. Established in 2009, this finding declared greenhouse gases like carbon dioxide a danger to public health, enabling regulations on emissions from vehicles and power plants. Its repeal, announced by the Trump administration, argues that such regulations impose unnecessary economic burdens, estimated at $1.3 trillion in savings. However, public health experts counter that this ignores mounting evidence of climate-driven harms.

Communities in areas like Louisiana's Cancer Alley, home to over 170 petrochemical plants, stand to suffer most. These predominantly minority and low-income regions already face elevated cancer and respiratory illness rates due to fine particle pollution from fossil fuels. Without the endangerment finding, tighter controls on emissions could lapse, exacerbating air quality issues. Recent studies link these pollutants to higher premature death rates, with projections showing increases in heat-related illnesses, worsened allergies, and preterm births as global temperatures rise.

Beyond air pollution, climate change amplifies other threats. Wildfires in Argentina and Chile in January 2026, fueled by drought and extreme heat, highlight how shifting weather patterns spread respiratory hazards through smoke. In the U.S., similar events disrupt food supplies and increase dust-related illnesses. Vector-borne diseases, such as dengue and malaria, are expanding ranges; a 2026 study estimates half a billion more people at risk by mid-century due to warmer conditions favoring mosquitoes.

Tensions arise between stakeholders. Industry groups welcome deregulation for reduced compliance costs, but health organizations, including the American Lung Association, plan lawsuits, calling the repeal unlawful. Non-obvious trade-offs include short-term job preservation in fossil fuel sectors versus long-term healthcare expenditures, potentially in the hundreds of billions. Partisan divides deepen, with critics labeling the move a denial of scientific consensus from bodies like the National Academies.